George Kollias, Founder of INOLYSIS, Invited Speaker at Keystone Symposia on Stromal Immunology and Fibrosis (2026)

We are pleased to share that George Kollias, participated as an invited speaker at the Keystone Symposia on Stromal Immunology in Health and Disease, held jointly with Fibrosis: Cross Organ Pathology and Pathways to Clinical Development (February 2–5, 2026, Fairmont Banff Springs, Banff, AB, Canada).

This leading international conference brought together researchers, clinicians, and industry experts to explore stromal biology, immune regulation, and fibrosis across tissues.

George’s presentation, entitled “Fibroblasts Transitioning from Homeostasis to Inflammation to Fibrosis,” contributed to discussions at the forefront of fibrotic disease research, particularly around targeting fibroblast-driven mechanisms as a basis for new therapeutic strategies. These mechanisms are central to INOLYSIS’ differentiated approach to developing novel therapies for fibrotic and inflammatory diseases.